Establishment of a Chikungunya virus pseudotype system strictly dependent on viral protein expression
Abstract
Chikungunya virus (CHIKV) is an enveloped RNA virus that causes Chikungunya fever in humans. It is classified into the arboviruses (arthropod-borne viruses) and is transmitted by mosquitoes. Therefore, mosquitoes can replicate many types of cells derived from mammals or insects. In this study, we tried to establish the widely useable Chikungunya virus pseudotype-system adapting various viral species, and we demonstrated the production of Chikungunya pseudotype virus baring the envelope protein from two different viral families, Coronaviridae or Rhabdoviridae i.e., severe acute respiratory syndrome coronavirus 2 spike protein (CoV-2-S) or vesicular stomatitis virus glycoprotein (VSV-G), respectively. We found that the capsid protein of Chikungunya virus is not always necessary in the formation of Chikungunya virus-based pseudotypes, but that the capsid protein increases the efficiency of expression of the sub-genomic RNA which codes the labeled genes. Our established pseudotype virus-producing system supplied a sufficient titer of virions for application to most virological experiments that showed more than 104 focus forming units (FFU)/ml. The pseudotype infections were strictly dependent on compatibility between the viral envelope protein and its receptor and there was no false-positive background infection. Our established pseudotype virus system can be used as a robust platform to study various virus infections and for screening and in-depth evaluation of neutralizing antibodies and antiviral agents.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 22th percentile
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Phosphatidylserine within the Viral Membrane Enhances Chikungunya Virus Infectivity in a Cell-type Dependent Manner
K. L. Miazgowicz, J. M. Reyes Ballista, … M. A. Brindley·bioRxiv·Jan 14, 2022
- Beyond members of the Flaviviridae family, sofosbuvir also inhibits chikungunya virus replication
A. Ferreira, P. Reis, … T. Souza·bioRxiv·Jul 2, 2018
- Chikungunya Virus Release is Reduced by TIM-1 Receptors Through Binding of Envelope Phosphatidylserine
J. M. Reyes Ballista, A. J. Hoover, … M. A. Brindley·Journal of VirologyPeer-reviewed·Aug 20, 2024
- Evaluation of neutralizing antibodies produced by papaya mosaic virus nanoparticles fused to the E2EP3 peptide epitope of Chikungunya envelope
H. ROTHAN·bioRxiv·Feb 28, 2020
- Spike protein E2 of chikungunya virus: a plant-based vaccine exhibited potent immunogenicity in BALB/c mice
Sadia Qamar, Monika Dalal, … Mohammad Irfan Qureshi·bioRxiv·Aug 21, 2025
- Live-Attenuated CHIKV Vaccine with Rearranged Genome Replicates in vitro and Induces Immune Response in Mice
Irina Tretyakova, Joongho J. Joh, … Peter Pushko·PLoS neglected tropical diseasesPeer-reviewed·Apr 22, 2024